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Abstract 
Objectives: Uncontrolled hypertension negatively impacts on mortality. This study aimed to evaluate 
the impact of a pharmacist-driven patient counselling and education model to empower hypertensive 
patients on chronic medication. Methods: An operational research project with a quasi-experimental 
design including an intervention group (55 patients) and a control group (31 patients) of chronic 
hypertensive patients. Data were collected with interview-administered questionnaires and analysed 
using SAS® version 9.4. Pharmacist interventions included an educational diary on hypertension 
PDQDJHPHQWDQGSDWLHQWFRXQVHOOLQJ)LQGLQJV7KHUHZDVDLPSURYHPHQWLQSDWLHQWV¶
understanding of what normal blood pressure (BP) is in the intervention group compared to the 
control group (p< 0.001). A 9.1% improvement was also observed in the intervention group in 
knowledge about the fact that systolic and diastolic BP are both important in controlling hypertension, 
with no change in the control group. After the intervention, 40.0% of patients versus 17.9% in the 
FRQWUROJURXSKDGDGHTXDWHNQRZOHGJHFRUUHFWDQVZHUVDERXWK\SHUWHQVLRQand its 
management. Pharmacist interventions were well received by the majority of patients (>90%). 
Conclusions: A pharmacist driven pDWLHQWFRXQVHOOLQJDQGHGXFDWLRQPRGHOFDQKHOSLPSURYHSDWLHQWV¶
hypertension knowledge and BP control. These should increasingly become routine, aiming to 




South Africa has one of the highest prevalence rates of hypertension worldwide reaching 77.9% in 
those above 50,[1]  with high rates generally among African countries.[1.2]  Hypertension is the fastest 
growing non-communicable disease (NCD) in South Africa, with hypertension the major cause of 
death among patients with NCDs.[3] Overall, hypertension accounts for most deaths due to stroke and 
heart attacks across Africa.[1,2,4]    
 
Primary Healthcare (PHC) facilities are the foundation of the South African healthcare system and 
where the majority of hypertensive patients are managed; however, there are concerns with blood 
pressure (BP) control.[5,6]  Hypertensive patients should receive counselling and education when 
visiting PHC facilities, as well as be satisfied with their treatment to reduce future morbidity and 
mortality.[3,7-9]  
 
Written hypertension information leaflets or booklets are effective with improving knowledge about 
hypertension and subsequent medicine taking,[10,11]  with written information serving as a continuous 
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reliable source about the disease and its treatment.[8,11]  Patients should receive such information 
during counselling, which currently does not always happen in South Africa.[6] Such booklets provide a 
platform for both pharmacists and patients to develop hypertension care plans, empowering patients 
to become more personally involved with their treatment.[10,11] This is important in South Africa given 
concerns with BP control,[6,12] and following the implementation of the Central Chronic Medicines 
Dispensing and Distribution (CCMDD) programme to enhance access to medicines for patients in the 
public system in South Africa.[12] Within the CCMDD programme, medicines are packaged and 
distributed free of charge to SDWLHQWV¶ nearest pick-up point to aid adherence.[12] 
 
Consequently, the main aim of this study was to evaluate the impact of a pharmacist-driven patient 
counselling and education model in South Africa in PHCs to empower hypertensive patients with 
NQRZOHGJH7KHVSHFLILFREMHFWLYHVZHUHWRGHWHUPLQHK\SHUWHQVLYHSDWLHQWV¶ knowledge of their 
disease and its management, BP control, and self-reported adherence to treatment before and after 
WKHLPSOHPHQWDWLRQRIWKHSKDUPDFLVWLQWHUYHQWLRQ6XEVHTXHQWO\WRGHWHUPLQHK\SHUWHQVLYHSDWLHQWV¶




Operational reserach project with a quasi-experimental design among patients with hypertension 
attending PHC facilities in the Vhembe District of Limpopo Province.[13] The original design used 
stratified random sampling to allocate 60 out of 120 facilities to intervention and control groups. The 
intention was to initially approach 600 patients based on an estimated 50% drop out rate following 
statistical advice. Stratification was undertaken according to municipality, type and size to ensure 
each group was balanced and comparable. However, challenges such as community strikes and riots 
meant only 50 PHCs eventually took part, 25 in each group.  
 
Data were collected on the scheduled clinic-return date over six months by trained pharmacists, with 
a 4-month interval for each patient between baseline and post-intervention visits. Randomisation was 
used to select up to 15 hypertensive patients per facility based on the availability and willingness of 
patients who met the inclusion criteria on the day of data collection, which was principally adults on 
chronic antihypertensive treatment for more than six months and without organ damage. The first 
random patient was approached, enrolled if willing, and when completed, the next available patient 
was approached. This process continued resulting in 253 patients being eventually enrolled in the 
study, 138 in the intervention group and 115 in the control group. These differences reflect that only 
patients with baseline- and post-intervention data were initially included in the analysis. 
 
Patients in both groups received usual care and were requested to collect their medicines monthly. 
The intervention group was exposed to a pharmacist intervention at enrolment with the control group 
introduced to the intervention at the end. The pharmacist intervention included a hypertension 
information diary for daily use, with 15-30 minutes patient counselling and education about 
hypertension and its management, and the correct use of the diary. The diary also had space for 
patients to record their BP, lifestyle changes and any adverse effects. The counselling was performed 
on the first visit immediately after the questionnaire was administered.  
 
A structured questionnaire was developed based on previously published studies,[14-16] translated into 
local languages and piloted amongst 22 hypertensive patients from another district in the Province 
with a similar socioeconomic status as the study PHCs. This assisted in simplifying the language 
used, helping to avoid different interpretations. Training of all data collectors and cross-checking of 
entered data took place to ensure the validity and reliability of the data. 
 
The validity of the results was supported by the study design in which the control group was exposed 
to the same conditions as the intervention group except for the patient counselling and education 
model (intervention). Demographic data included educational status with patients with formal 
education (completed at least primary school and up to secondary school- and tertiary education) 
were classified as educated.[17] 
 
3DWLHQWV¶NQRZOHGJHRQK\SHUWHQVLRQDQGLWVPDQDJHPHQWVHOI-reported adherence and lifestyle 
habits, were assessed for both groups. Patients knowledge testing questions were classified into 4 
groups including (1) understanding and knowledge of hypertension; (2) Knowledge on BP 
measurement and readings; (3) Knowledge about medication and lifestyle and (4) Knowledge of the 
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dangers of uncontrolled high BP.  Adequate knowledge about hypertension was considered as 75% 
of answers provided correctly.[18] Patients rated their adherence to treatment using six pre-defined 
categorised responses, i.e. excellent, very good, good, fair, poor and very poor), previously used in 
adherence studies.[9,19] Previous studies had revealed that participants felt more comfortable and 
confident with words compared to numbers for rating adherence, and a 30-day recall performed better 
compared to a three-day or seven-day recall.[19,20]  
 
Sensitivity analyses were performed using Chi-square tests. 3DWLHQWV¶%3as taken by the nurse at the 
facility on the day of data collection was recorded on their clinic patient record card. BP recordings 
between enrolment and study end were collected retrospectively. At the study end, patients with 
uncontrolled BP were counseled on medication adherence and referred to the medical practitioner to 
assess their treatment regimen and discuss future care. 
 
Data were captured electronically RQ0LFURVRIW([FHOResponses to open-ended questions were 
typed-up manually and grouped into categories. Data were analysed using SAS® version 9.4. 
Baseline characteristics between the intervention group and the control groups were compared using 
WKH)LVKHU¶V([DFW7HVW3RVLWLYHFKDQJHVLQK\SHUWHQVLRQPDQDJHPHQWNQRZOHGJHIURPEDVHOLQHWR
the final post-intervention visit in the intervention and control groups was determined using the same 
test. A two-sided p-YDOXHLQGLFDWHGVWatistical significance.  
 
The primary outcome was the proportion of patients with adequate knowledge of the management of 
hypertension after the pharmacist intervention. Secondary outcomes included (i) positive changes for 
individual variables from baseline to post-intervention; (ii) decrease in systolic and diastolic BP; (iii) 
proportion of patients with controlled BP; and (iv) the proportion of patients being satisfied with the 
pharmacist intervention. The pharmacist intervention was considered acceptable if there was at least 
80% agreement or satisfaction amongst all respondents.  
 
Ethical clearance for the study was obtained from the Medunsa Research Ethics Committee of the 
University of Limpopo, currently Sefako Makgatho Health Sciences University (MRECH 27/2014:PG). 
Permission to conduct the study was obtained from the Limpopo Department of Health and the 
Vhembe District Executive Manager. All patients provided written informed consent to participate. 
 
3. Results  
 
Losses to follow-up resulted in a final sample of 55 patients in the intervention group and 31 in the 
control group. 
 
Table 1 shows that females predominated with no differences in baseline characteristics between the 
groups. Comorbidities were present in 33.3% of control group and 50.9% among intervention patients, 
of which diabetes was most common. Other co-morbidities included shortness of breath, ulcers, heart 












Gender; n (%) Female  49 (89.1) 25 (80.7) 
0.337 Male 6 (10.9) 6 (19.4) 
Age (years) Mean ± SD 62.1 ± 11.2 65.9 ± 12.0 0.145 
Median (IQR) 63 (53 ± 67) 65 (59 ± 76) - 
Marital status; n (%) Married  27 (49.1) 18 (58.1) 
0.755 
Divorced  3 (5.5) 0 
Never married 9 (16.4) 4 (12.9) 
Separated  1 (1.8) 0 
Widowed  15 (27.2) 9 (29.0) 
Education; n (%) Educated  23 (41.8) 13 (41.9) 
1.000 Uneducated  32 (58.2) 18 (58.1) 
Comorbidities; n (%) Comorbidity 27 (49.1) 10 (33.3) 
0.178 No comorbidity 28 (50.9) 20 (66.7) 
Diabetes as comorbidity 16 (29.6) 5 (16.7) 0.292 
Duration on 
treatment; n (%) 
1-5 years 14 (25.4) 9 (29.1) 
0.801 >5 years  41 (74.6) 22 (70.9) 
Blood pressure; 
mean ± SD 
Systolic blood pressure 138.6 ± 21.8 138.7 ± 21.6 0.990 
Diastolic blood pressure  78.9 ± 9.6 82.6 ± 11.1 0.118 
Weight and BMI; 
mean±SD 
Weight (kg) 76.7 ± 14.5 76.6 ± 14.2 0.962 
BMI 30.9 ± 6.8 (n=32) 30 ± 4.8 (n=10) 0.673 
*)LVKHU¶V([DFW7HVWCompleted at least primary education; SD=Standard deviation; IQR=Interquartile range; BMI=Body mass 
index  
 
Before the intervention, approximately 90% of patients in both groups did not have adequate 
knowledge about hypertension management. This changed with 40.0% of patients in the intervention 
group and 17.9% in the control group having adequate knowledge, although not statistically 
significant. 
 
Table 2 shows the positive changes for each knowledge question and self-reported adherence from 
baseline to post-intervention visits for both groups.  However, although a number of positive changes 
were observed after the pharmacist intervention, the only statistically significant (p<0.001) 





Table 2: Positive changes in hypertension management knowledge from baseline to the final post-
intervention visit in intervention and control groups 
 
Statement 
Positive changes from baseline to post-
intervention 
Intervention group Control group 
Number/ 
sample size % 
Number/ 
sample size % 
Understanding and knowledge of hypertension 
Definition of hypertension 20/49 40.8 14/29 48.3 
Normal blood pressure 17/49 34.7 0/25 0.0 
Causes of high blood pressure 13/53 24.5 6/28 21.4 
Benefits of taking medicines for high BP correctly 9/45 20.0 4/27 14.8 
Knowledge on BP measurement and readings 
Importance of BP numbers  5/55 9.1 0/29 0.0 
Meaning of the reported BP numbers 6/55 10.9 1/28 3.57 
BP readings written down on paper 13/55 23.6 3/29 10.3 
Knowledge about medication and lifestyle 
Taking hypertension medicines as prescribed is 
necessary and important 0/55 0.0 0/31 0.0 
Exercise is important to control high BP 1/49 2.0 0/27 0.0 
Smoking is dangerous to hypertensive patients 2/49 4.1 1/29 3.5 
Alcohol is dangerous to hypertensive patients 2/50 4.0 2/29 6.9 
Can do something to lower high BP 16/53 30.2 9/30 30.0 
Knowledge about hypertension complications and its dangers 
Dangers of uncontrolled high BP 6/55 10.9 2/28 7.1 
Self-reported medication adherence 6/55 10.9 12/31 38.7# 
NB: #Significant improvement in the control group; BP = Blood pressure 
 
19.5% patients in the intervention group and 10.7% in the control group who had uncontrolled BP at 
baseline had controlled BP post-intervention (Table 3). However, this did not reach statistical 
significance. 
 
Table 3: Changes in mean systolic and diastolic blood pressure (BP) from baseline to post-
intervention for the intervention and control groups 
 
 
Mean blood pressure; mmHg (SD) 
N Intervention group n Control group 
Mean systolic BP Baseline  52 138.6 (21.8) 31 138 (21.6) 
Post-intervention 55 135.7 (22.0) 28 138.4 (20.1) 
Change: Baseline 
to post-
intervention* 40 -4.6 28 0.75 
p-value  0.122  0.869 
Mean diastolic BP Baseline  52 78.9 (9.6) 31 82.6 (11.1) 
Post-intervention 55 76.6 (11.3) 28 79.1 (12.9) 
Change: Baseline 
to post-
intervention* 40 -2.5 28 -1.46 
p-value 40 0.272 28 0.496 
Intervention group 
vs. control group* p-value 40 0.584 28 0.379 
NB: *Change was calculated only in patients with baseline and post-intervention data  
 
7KHPDMRULW\RISDWLHQWVLQWKHLQWHUYHQWLRQJURXSH[SUHVVHGWKHLUVDWLVIDFWLRQZLWKYDULRXV









Most (97.7%) patients found the dairies easy to use, motivated them to change their lifestyle, and 
become more health wise. 90.9% stated the studies aided them to remember their medicines and 
clinic appointments. 90% of the patients who were exposed to the diary expressed their satisfaction 
with its content and use. Only a minority found them time consuming (43.2%). Family members also 
supported patients helping them to improve their BP control. This included reading from the diaries for 
those having difficulties, helped by trust in the information provided with this typically shared with 
family members and friends. Some patients though preferred face-to-face counselling sessions with 
the pharmacist instead of an information booklet, which needs to be factored into any future 
programme. 
 
4. Discussion  
 
It was encouraging to see pharmacist-driven interventions being well received, similar to Dawes et al 
in which a patient booklet was well received.[10] Some patients subsequently requested this 
pharmacist-driven intervention should be routinely implemented in PHCs throughout South Africa to 
assist with reducing BP. The strengthening of patient-pharmacist relationships could help improve 
satisfaction with healthcare services generally and treatment outcomes in the future.  
 
There was also an indication that ZULWWHQLQIRUPDWLRQFDQLPSURYHSDWLHQWV¶NQRZOHGJHRIK\SHUWHQVLRQ
with patients sharing their information with family and friends. In addition, those experiencing reading 
difficulties were assisted by family members. These factors should be considered as South Africa 
instigates a number of measures to improve adherence to medicines in patients with NCDs including 
the CCMDD programme.[12] 
 
7KHJUHDWHUFKDQJHLQSDWLHQWV¶NQRZOHGJHRIZKDWK\SHUWHQVLRQLVLQWKHFRQWUROJURXSPD\EHGXHWR
patient curiosity after being asked what hypertension is during enrolment versus the knowledge 
provided to the intervention group. In addition, this knowledge was only provided once in the 
intervention group at the start, and forgetfulness could be an issue in the intervention group.[11]  
 
+RZHYHUWREDODQFHWKLVWKHUHZDVDVLJQLILFDQWLPSURYHPHQWLQSDWLHQWV¶NQRZOHGJHRIZKDWLV
normal BP in the intervention group (Table 2), similar to other studies.[10,11,21] A positive change in the 
intervention group in knowing that both systolic and diastolic BP readings are important for controlling 
K\SHUWHQVLRQLVHQFRXUDJLQJDVWKLVLVOLNHO\WRLPSURYHSDWLHQWV¶involvement in the management of 
their disease.[22]  
 
A positive change was also seen in BP control, with a greater reduction in the intervention group 
(Table 3); however, this did not reach significance. This may be due to high dropout rates as 
significant changes have been seen in BP control in patients with hypertension after pharmacist 




A negative finding was that self-reported medication adherence significantly improved in the control 
group compared to the intervention group (Table 2). This may be due to improved relationships 
between patients and pharmacists resulting in honest answers.[23] Consequently, low adherence in the 
intervention group may be a better representation of actual practice,[23,24] with previous studies 
showing that knowledge is the most significant factor in medicine adherence among hypertensive 
patients.[25] 
 
With improved medicines accessibility through the CCMDD programme in South Africa,[12] it will be 
important to strengthen patients¶ involvement in their treatment. Such programmes should also 
include potential ways of addressing illiteracy among patients where this is a concern to help 
complete hypertension diaries.  
 
The main limitation was the high dropout rate due to the inaccessibility of some of the PHCs. Cross-
contamination between the intervention and control groups cannot be excluded. We have also not 
been able to compare our findings as we are unaware of studies that have jointly assessed the 
combination of patient diaries and counselling. Despite these limitations, we believe our findings give 
a basis for improving the future care of hypertensive patients in PHCs in South Africa.  
 
In conclusion, encouragingly patients in PHC facilities in South Africa were highly satisfied with the 
pharmacist intervention, laying a strong foundation for improving collaboration in the future. 
Consequently, it is recommended that this intervention model be further developed and tested, with a 
greater focus on lifestyle changes and clinical outcomes. Pharmacists should also help routinely 
instigate and review patient diaries to help improve future control of blood pressure. 
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